首页> 外文期刊>Diabetes, metabolic syndrome and obesity: targets and therapy >Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study
【24h】

Nomogram for the Risk of Diabetic Nephropathy or Diabetic Retinopathy Among Patients with Type 2 Diabetes Mellitus Based on Questionnaire and Biochemical Indicators: A Cross-Sectional Study

机译:基于调查问卷和生化指标的2型糖尿病患者患有糖尿病肾病或糖尿病患者患者患有糖尿病肾病或糖尿病性视网膜病的风险:横断面研究

获取原文
       

摘要

Purpose: This study aimed to develop a diabetic nephropathy (DN) or?diabetic retinopathy (DR) incidence risk nomogram in China’s population with type 2 diabetes mellitus (T2DM) based on a community-based sample. Methods: We carried out questionnaire evaluations, physical examinations and biochemical tests among 4219 T2DM patients in Shanghai. According to the incidence of DN and DR, 4219 patients in our study were divided into groups of T2DM patients with DN or DR, patients with both, and patients without any complications. We successively used least absolute shrinkage and selection operator regression analysis and logistic regression analysis to optimize the feature selection for DN and DR. To ensure the accuracy of the results, we carried out multivariable logistic regression analysis of the above significant risk factors on the sample data for both DN and DR. The selected features were included to establish a prediction model. The C-index, calibration plot, curve analysis and internal validation were used to validate the distinction, calibration, and clinical practicality of the model. Results: The predictors in the prediction model included disease course, body mass index (BMI), total triglycerides (TGs), systolic blood pressure (SBP), postprandial blood glucose (PBG), haemoglobin A1C (HbA1c) and blood urea nitrogen (BUN). The model displayed moderate predictive power with a C-index of 0.807 and an area under the receiver operating characteristic curve of 0.807. In internal verification, the C-index reached 0.804. The risk threshold was 16– 75% according to the analysis of the decision curve, and the nomogram could be applied in clinical practice. Conclusion: This DN or DR incidence risk nomogram incorporating disease course, BMI, TGs, SBP, PBG, HbA1c and BUN can be used to predict DN or DR incidence risk in T2DM patients. The research team has developed an online app based on a clinical prediction model incorporating risk factors for rapid and simple prediction.
机译:目的:本研究旨在基于基于社区的样本,在中国患有2型糖尿病(T2DM)的中国人口中的糖尿病肾病(DN)或?糖尿病视网膜病(DR)发病率罗马图。方法:我们在上海4219 T2DM患者中进行了调查问卷评估,体检和生化试验。根据DN和DR的发病率,我们研究中的4219名患者分为患有DN或DR,患者的T2DM患者,患者,患者没有任何并发​​症。我们连续使用最不绝对的收缩和选择操作员回归分析和Logistic回归分析,以优化DN和DR的特征选择。为了确保结果的准确性,我们对DN和DR的样本数据进行了多变量的逻辑回归分析。包括所选功能以建立预测模型。 C折射率,校准图,曲线分析和内部验证用于验证模型的区别,校准和临床实用性。结果:预测模型中的预测变量包括疾病过程,体重指数(BMI),总甘油三酯(TGS),收缩压(SBP),后血糖(SBP),后血糖血糖(PBG),血红蛋白A1C(HBA1C)和血尿尿素氮(BUN )。该模型以0.807的C折射率显示适中的预测功率,接收器的接收器的区域为0.807。在内部验证中,C索引达到0.804。根据决策曲线的分析,风险阈值为16-75%,并且铭文图可以应用于临床实践。结论:该DN或DR发病风险载体抑制疾病过程,BMI,TGS,SBP,PBG,HBA1C和BUN可用于预测T2DM患者的DN或DR发病风险。该研究团队在基于临床预测模型的临床预测模型中开发了一个在线应用程序,该模型包括快速和简单的预测的危险因素。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号